The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Characterization of dominant T-cell clones by T-cell receptor (TCR) deep sequencing as a potential predictive biomarker to neoadjuvant trastuzumab (tras) in HER2-positive (HER2+) breast cancer.
 
David B. Page
No Relationships to Disclose
 
Yong Hannah Wen
No Relationships to Disclose
 
Edi Brogi
No Relationships to Disclose
 
Jianda Yuan
Patents, Royalties, Other Intellectual Property - Adaptive Biotechnologies
 
Ryan O Emerson
Employment - Adaptive Biotechnologies
Stock and Other Ownership Interests - Adaptive Biotechnologies
 
Sujata Patil
No Relationships to Disclose
 
Chau T. Dang
Research Funding - Roche/Genentech
 
Larry Norton
No Relationships to Disclose
 
Clifford A. Hudis
Other Relationship - Breast Cancer Research Foundation
 
Heather L. McArthur
Consulting or Advisory Role - Celgene
Research Funding - Bristol-Myers Squibb (Inst)